Delivery Order SPE2DB22D2006-SPE2DB23FW2VT

Award Date 9/13/23
Potential Completion Date 9/14/23
Potential Value $77K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $383,210 delivery order to Amerisourcebergen Drug Corporation for HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and will provide hepatitis B vaccines to support DLA and Department of Defense immunization programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three day period concluding on August 28, 2023. No subcontractors...
The Defense Logistics Agency awarded a $46,000 delivery order to Amerisourcebergen Drug Corporation for HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The firm fixed price order is for the delivery of Hepatitis B vaccines to a location in Conshohocken, Pennsylvania. Performance will take place between September 18-19, 2023. The award was made using an indefinite-delivery/indefinite-quantity contract vehicle, though further details about the underlying contract were not provided. Amerisourcebergen will...
The Defense Logistics Agency awarded a $38,321 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561674277 HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and services in support of DLA missions. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all items to be delivered by August 1, 2023. No subcontractors or set aside...
The Defense Logistics Agency Troop Support Medical awarded a $3,385 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561909721 HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. This delivery order was issued against an unspecified indefinite-delivery/indefinite-quantity contract vehicle and requires the prime contractor, Amerisourcebergen, to provide the specified hepatitis B...
The Defense Logistics Agency awarded a $95,802.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561537036 HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is for the delivery of HEPLISAV-B vaccine syringes and has a period of performance from July 17, 2023 through July 18, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support of the United States...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $1,916 to Amerisourcebergen Drug Corporation for HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. Performance will occur in Conshohocken, Pennsylvania under contract number 4562072369. As a division of Amerisourcebergen Corporation, Amerisourcebergen Drug Corporation will fulfill the order for the hepatitis B vaccine and associated syringes to support the medical readiness programs of the...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,245.55 to Amerisourcebergen Drug Corporation for 4562001922 HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. Performance will occur in Conshohocken, Pennsylvania over a one day period concluding on August 31, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will serve as the prime contractor to supply this hepatitis B vaccine product in support of the Department of...
The Defense Logistics Agency awarded a $76,642 delivery order to Amerisourcebergen Drug Corporation for HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The firm fixed price order is for the delivery of Hepatitis B vaccine syringes to a location in Conshohocken, Pennsylvania. Amerisourcebergen will fulfill the order as the prime contractor by the specified completion date of June 30, 2023. No additional subcontractors or set aside designations were indicated in the award provided. The Defense Logistics...
The Defense Logistics Agency awarded a $2,644.06 firm fixed price delivery order to Amerisourcebergen Drug Corporation for HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The order period of performance is July 18-19, 2023. No set aside designation or subcontractors are indicated. The Defense Logistics Agency manages the Department of Defense's global logistics network, and this order for hepatitis B...
The Defense Logistics Agency awarded a $766 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562180733 HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The order is associated with DLA's pharmaceutical supply chain support for the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over one day in September 2023. No set aside designation or subcontractors are indicated. This order supports DOD's vaccine distribution programs by providing a hepatitis...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB23FW2VT
    Delivery Order

The Defense Logistics Agency awarded a $76,642 delivery order to Amerisourcebergen Drug Corporation for HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and will provide the hepatitis B vaccine to support Department of Defense immunization programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day. No subcontractors or set aside designations were identified. This award draws from DLA's portfolio of medical supply contracts to efficiently procure critical pharmaceuticals for the military's force health protection mission.

Generated 12/14/23, 8:30 PM